BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36436996)

  • 1. "Nutrient-Repositioning"-Unexpected Amino Acid Functions.
    Kitaura Y; Hayamizu K; Wada E; Petrova B; Nagao K
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S134-S136. PubMed ID: 36436996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-Acid-Conjugated Natural Compounds: Aims, Designs and Results.
    Arifian H; Maharani R; Megantara S; Gazzali AM; Muchtaridi M
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems-level analysis of drug-target-disease associations for drug repositioning.
    Rutherford KD; Mazandu GK; Mulder NJ
    Brief Funct Genomics; 2018 Jan; 17(1):34-41. PubMed ID: 28968683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning in target prediction and drug repositioning: Recent advances and challenges.
    Yu JL; Dai QQ; Li GB
    Drug Discov Today; 2022 Jul; 27(7):1796-1814. PubMed ID: 34718208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
    Jin G; Wong ST
    Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repositioning: A Unique Approach to Refurbish Drug Discovery.
    Kale MA; Shamkuwar PB; Mourya VK; Deshpande AB; Shelke PA
    Curr Drug Discov Technol; 2022; 19(1):e140122192307. PubMed ID: 33726652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence unifies knowledge and actions in drug repositioning.
    Yin Z; Wong STC
    Emerg Top Life Sci; 2021 Dec; 5(6):803-813. PubMed ID: 34881780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput drug repositioning for the discovery of new treatments for Chagas disease.
    Bellera CL; Sbaraglini ML; Balcazar DE; Fraccaroli L; Vanrell MC; Casassa AF; Labriola CA; Romano PS; Carrillo C; Talevi A
    Mini Rev Med Chem; 2015; 15(3):182-93. PubMed ID: 25769967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the flexibility of the cellular amination network in
    Schulz-Mirbach H; Müller A; Wu T; Pfister P; Aslan S; Schada von Borzyskowski L; Erb TJ; Bar-Even A; Lindner SN
    Elife; 2022 Jul; 11():. PubMed ID: 35876664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases.
    Tanabe M; Sakate R; Nakabayashi J; Tsumura K; Ohira S; Iwato K; Kimura T
    Sci Rep; 2023 Nov; 13(1):19358. PubMed ID: 37938624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
    Kwon OS; Kim W; Cha HJ; Lee H
    Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Drug Repositioning and Prediction Techniques: A Concise Review.
    He S; Liu X; Ye X; Tetsuya S
    Curr Top Med Chem; 2022; 22(23):1897-1906. PubMed ID: 35301952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating drug repositioning opportunities in FDA drug labels through topic modeling.
    Bisgin H; Liu Z; Kelly R; Fang H; Xu X; Tong W
    BMC Bioinformatics; 2012; 13 Suppl 15(Suppl 15):S6. PubMed ID: 23046522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a Novel Treatment for Neurological Disorders by Drug Repositioning].
    Saito S; Ihara M
    Brain Nerve; 2019 Sep; 71(9):936-942. PubMed ID: 31506395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.